Literature DB >> 22289517

Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors.

Eric B Schneider1, Omar Hyder, Benjamin S Brooke, Jonathan Efron, John L Cameron, Barish H Edil, Richard D Schulick, Michael A Choti, Christopher L Wolfgang, Timothy M Pawlik.   

Abstract

BACKGROUND: Data on readmission as well as the potential impact of length of stay (LOS) after colectomy for colon cancer remain poorly defined. The objective of the current study was to evaluate risk factors associated with readmission among a nationwide cohort of patients after colorectal surgery. STUDY
DESIGN: We identified 149,622 unique individuals from the Surveillance, Epidemiology, and End Results-Medicare dataset with a diagnosis of primary colorectal cancer who underwent colectomy between 1986 and 2005. In-hospital morbidity, mortality, LOS, and 30-day readmission were examined using univariate and multivariate logistic regression models.
RESULTS: Primary surgical treatment consisted of right (37.4%), transverse (4.9%), left (10.5%), sigmoid (22.8%), abdominoperineal resection (7.3%), low anterior resection (5.6%), total colectomy (1.2%), or other/unspecified (10.3%). Mean patient age was 76.5 years and more patients were female (52.9%). The number of patients with multiple preoperative comorbidities increased over time (Charlson comorbidity score ≥3: 1986 to 1990, 52.5% vs 2001 to 2005, 63.1%; p < 0.001). Mean LOS was 11.7 days and morbidity and mortality were 36.5% and 4.2%, respectively. LOS decreased over time (1986 to 1990, 14.0 days; 1991 to 1995, 12.0 days; 1996 to 2000, 10.4 days; 2001 to 2005, 10.6 days; p < 0.001). In contrast, 30-day readmission rates increased (1986 to 1990, 10.2%; 1991 to 1995, 10.9%; 1996 to 2000, 12.4%; 2001 to 2005, 13.7%; p < 0.001). Factors associated with increased risk of readmission included LOS (odds ratio = 1.02), Charlson comorbidities ≥3 (odds ratio = 1.27), and postoperative complications (odds ratio = 1.17) (all p < 0.01).
CONCLUSIONS: Readmission rates after colectomies have increased during the past 2 decades and mean LOS after this operation has declined. More research is needed to understand the balance and possible trade off between these hospital performance measures for all surgical procedures.
Copyright © 2012 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22289517     DOI: 10.1016/j.jamcollsurg.2011.12.025

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  82 in total

1.  Risk factors for 30-day hospital readmission among general surgery patients.

Authors:  Michael T Kassin; Rachel M Owen; Sebastian D Perez; Ira Leeds; James C Cox; Kurt Schnier; Vjollca Sadiraj; John F Sweeney
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

2.  A validated, risk assessment tool for predicting readmission after open ventral hernia repair.

Authors:  P A Baltodano; Y Webb-Vargas; K C Soares; C W Hicks; C M Cooney; P Cornell; K K Burce; T M Pawlik; F E Eckhauser
Journal:  Hernia       Date:  2015-08-19       Impact factor: 4.739

3.  Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP.

Authors:  Donald J Lucas; Adil Haider; Elliot Haut; Rebecca Dodson; Christopher L Wolfgang; Nita Ahuja; John Sweeney; Timothy M Pawlik
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

4.  Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.

Authors:  Gauree Gupta Konijeti; Mark G Shrime; Ashwin N Ananthakrishnan; Andrew T Chan
Journal:  Gastrointest Endosc       Date:  2013-11-18       Impact factor: 9.427

5.  Higher Charlson Comorbidity Index Scores are associated with readmission after orthopaedic surgery.

Authors:  Timothy Voskuijl; Michiel Hageman; David Ring
Journal:  Clin Orthop Relat Res       Date:  2013-11-26       Impact factor: 4.176

6.  Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.

Authors:  Gaya Spolverato; Hadia Maqsood; Alessandro Vitale; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; T Clark Gamblin; Carlo Pulitano; Todd W Bauer; Feng Shen; George Poultsides; Shishir Maithel; J Wallis Marsh; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-04-23       Impact factor: 3.452

7.  Identifying causes for high readmission rates after stoma reversal.

Authors:  Deborah S Keller; Zhamak Khorgami; Brian Swendseid; Sadaf Khan; Conor P Delaney
Journal:  Surg Endosc       Date:  2013-11-27       Impact factor: 4.584

8.  Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.

Authors:  Omar Hyder; Rebecca M Dodson; Hari Nathan; Joseph M Herman; David Cosgrove; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-13       Impact factor: 6.113

9.  Functional genomic analyses of the gut microbiota for CRC screening.

Authors:  Sergey R Konstantinov; Ernst J Kuipers; Maikel P Peppelenbosch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

10.  Variation in surgical-readmission rates and quality of hospital care.

Authors:  Thomas C Tsai; Karen E Joynt; E John Orav; Atul A Gawande; Ashish K Jha
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.